<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-3-1.anc" start="21545" end="21549" sStart="-1" offset="0" sid="null" wn="2147483647" wnkey="null" text="The Center constructs a file of medical records in a standardized, subdivided sequence (hospital admission notes and discharge summaries; neurologic consultation notes; reports of computed tomographic and magnetic resonance imaging of the head; reports of imaging of the heart by transthoracic and transesophageal echocardiography; copies of electrocardiograms; reports of imaging of cervicocephalic vasculature by angiography using conventional, computed tomographic, or magnetic resonance techniques or by ultrasonography; and reports of blood &lt;b&gt;work&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-3-1.anc" start="21545" end="21549" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="The Center constructs a file of medical records in a standardized, subdivided sequence (hospital admission notes and discharge summaries; neurologic consultation notes; reports of computed tomographic and magnetic resonance imaging of the head; reports of imaging of the heart by transthoracic and transesophageal echocardiography; copies of electrocardiograms; reports of imaging of cervicocephalic vasculature by angiography using conventional, computed tomographic, or magnetic resonance techniques or by ultrasonography; and reports of blood &lt;b&gt;work&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-3-1.anc" start="21545" end="21549" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="The Center constructs a file of medical records in a standardized, subdivided sequence (hospital admission notes and discharge summaries; neurologic consultation notes; reports of computed tomographic and magnetic resonance imaging of the head; reports of imaging of the heart by transthoracic and transesophageal echocardiography; copies of electrocardiograms; reports of imaging of cervicocephalic vasculature by angiography using conventional, computed tomographic, or magnetic resonance techniques or by ultrasonography; and reports of blood &lt;b&gt;work&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-3-1.anc" start="21545" end="21549" sStart="null" offset="0" sid="null" wn="2" wnkey="work%1:06:00::" text="The Center constructs a file of medical records in a standardized, subdivided sequence (hospital admission notes and discharge summaries; neurologic consultation notes; reports of computed tomographic and magnetic resonance imaging of the head; reports of imaging of the heart by transthoracic and transesophageal echocardiography; copies of electrocardiograms; reports of imaging of cervicocephalic vasculature by angiography using conventional, computed tomographic, or magnetic resonance techniques or by ultrasonography; and reports of blood &lt;b&gt;work&lt;/b&gt;)." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-3-1.anc" start="21545" end="21549" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="The Center constructs a file of medical records in a standardized, subdivided sequence (hospital admission notes and discharge summaries; neurologic consultation notes; reports of computed tomographic and magnetic resonance imaging of the head; reports of imaging of the heart by transthoracic and transesophageal echocardiography; copies of electrocardiograms; reports of imaging of cervicocephalic vasculature by angiography using conventional, computed tomographic, or magnetic resonance techniques or by ultrasonography; and reports of blood &lt;b&gt;work&lt;/b&gt;)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="41642" end="41646" sStart="null" offset="6" sid="r11.true.j.0479" wn="5" wnkey="true%5:00:00:typical:00" text="Thus, true associations can be missed due to misclassiflcation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="34173" end="34179" sStart="null" offset="121" sid="r11.strong.j.0328" wn="1" wnkey="strong%3:00:00::" text="With these estimates, we should have ample power to detect linkage between a marker and a moderately strong susceptibility locus, especially for locus-specific sib risks greater than 3." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="29900" end="29905" sStart="null" offset="253" sid="r8.state.n.0973" wn="2" wnkey="state%1:03:00::" text="The third (discordant) sibling is collected for purposes of determining potential nonpaternities in a sibship (more than 4 alleles) and for better estimating the proportion of alleles shared that are identical by state (in the absence of parents)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="15519" end="15525" sStart="null" offset="609" sid="r11.severe.j.0349" wn="1" wnkey="severe%5:00:00:intense:00" text="Because a SWISS proband might erroneously believe that a sibling never had a stroke, discordance is considered verified only if the sibling can be contacted for a structured telephone interview and gives negative answers to all 8 items on the Questionnaire for Verifying Stroke-Free Status (QVSFS) (Table 1) [ 57 58 ] . Discordant siblings are excluded if they are deemed unreliable historians in the opinion of the interviewer administering the QVSFS on the basis of global impression of moderate or severe impairment of speech, language, hearing, or memory." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="16971" end="16976" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="A certified study neurologist classifies the final subtype of the index stroke according to TOAST criteria [ 51 ] . To obtain certification the neurologist &lt;b&gt;reads&lt;/b&gt; the original manuscript describing the TOAST classification system and scores various patients presented in a series of stanardized clinical vignettes according to TOAST criteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="16971" end="16976" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="A certified study neurologist classifies the final subtype of the index stroke according to TOAST criteria [ 51 ] . To obtain certification the neurologist &lt;b&gt;reads&lt;/b&gt; the original manuscript describing the TOAST classification system and scores various patients presented in a series of stanardized clinical vignettes according to TOAST criteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="16971" end="16976" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="A certified study neurologist classifies the final subtype of the index stroke according to TOAST criteria [ 51 ] . To obtain certification the neurologist &lt;b&gt;reads&lt;/b&gt; the original manuscript describing the TOAST classification system and scores various patients presented in a series of stanardized clinical vignettes according to TOAST criteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="16971" end="16976" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="A certified study neurologist classifies the final subtype of the index stroke according to TOAST criteria [ 51 ] . To obtain certification the neurologist &lt;b&gt;reads&lt;/b&gt; the original manuscript describing the TOAST classification system and scores various patients presented in a series of stanardized clinical vignettes according to TOAST criteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="16971" end="16976" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="A certified study neurologist classifies the final subtype of the index stroke according to TOAST criteria [ 51 ] . To obtain certification the neurologist &lt;b&gt;reads&lt;/b&gt; the original manuscript describing the TOAST classification system and scores various patients presented in a series of stanardized clinical vignettes according to TOAST criteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="32257" end="32262" sStart="null" offset="0" sid="null" wn="6" wnkey="power%1:10:00::" text="For concordant sibling pairs, assuming that the candidate locus is near a stroke susceptibility locus (? &gt; 0), &lt;b&gt;power&lt;/b&gt; depends upon ? s (sibling recurrence risk) and ? o (offspring recurrence risk)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="39136" end="39141" sStart="null" offset="0" sid="null" wn="1" wnkey="powerfulness%1:07:00::" text="The weaknesses of the approach are its relative lack of &lt;b&gt;power&lt;/b&gt; and the low resolution of the linkage peaks identified." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="40010" end="40015" sStart="null" offset="0" sid="null" wn="1" wnkey="powerfulness%1:07:00::" text="As demonstrated in the case of diabetic nephropathy [ 74 ] , the discordant sibling pair approach can have greater &lt;b&gt;power&lt;/b&gt; than the concordant sibling pair approach in certain situations." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="32257" end="32262" sStart="null" offset="0" sid="null" wn="2147483644" wnkey="null" text="For concordant sibling pairs, assuming that the candidate locus is near a stroke susceptibility locus (? &gt; 0), &lt;b&gt;power&lt;/b&gt; depends upon ? s (sibling recurrence risk) and ? o (offspring recurrence risk)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="39136" end="39141" sStart="null" offset="0" sid="null" wn="2" wnkey="power%1:19:00::" text="The weaknesses of the approach are its relative lack of &lt;b&gt;power&lt;/b&gt; and the low resolution of the linkage peaks identified." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="40010" end="40015" sStart="null" offset="0" sid="null" wn="1" wnkey="powerfulness%1:07:00::" text="As demonstrated in the case of diabetic nephropathy [ 74 ] , the discordant sibling pair approach can have greater &lt;b&gt;power&lt;/b&gt; than the concordant sibling pair approach in certain situations." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="8947" end="8952" sStart="null" offset="20" sid="r9.paper.n.0406" wn="5" wnkey="paper%1:10:02::" text="The purpose of this paper is to describe the SWISS protocol in detail." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="37546" end="37550" sStart="null" offset="162" sid="r1.name.n.0087" wn="1" wnkey="name%1:10:00::" text="For this study, we have adopted the position that every member of a pedigree has the right to refuse to have personal information such as name, address, and medical history recorded in a research database." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="37546" end="37550" sStart="null" offset="162" sid="r1.name.n.0087" wn="1" wnkey="name%1:10:00::" text="For this study, we have adopted the position that every member of a pedigree has the right to refuse to have personal information such as name, address, and medical history recorded in a research database." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="37546" end="37550" sStart="null" offset="162" sid="r1.name.n.0087" wn="1" wnkey="name%1:10:00::" text="For this study, we have adopted the position that every member of a pedigree has the right to refuse to have personal information such as name, address, and medical history recorded in a research database." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="46214" end="46220" sStart="null" offset="797" sid="r8.live.v.0388" wn="1" wnkey="live%2:42:08::" text="One way of dealing with the logistic challenges inherent in genetic studies is to collect cases from an isolated population, such as Iceland [ 79 ] . However this approach requires an integrated health care database not easily applicable within the US health care model, and the required community consent is probably not possible within the US legal/ethical framework [ 80 81 ] . Logistic difficulties have been mitigated by the steady evolution in multicentered clinical trials that has occurred in the field of stroke research [ 82 ] . SWISS is designed as a multicenter clinical trial, and the use of a nationwide home health agency for phlebotomy service enables us to obtain blood from siblings living far away from one another." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="25318" end="25322" sStart="null" offset="63" sid="r9.full.j.0367" wn="6" wnkey="full%5:00:00:ample:00" text="The following information is collected on all living full siblings who return sibling response letters: name, date of birth, gender, name of the proband they are related to, twin status, home address, home phone number, e-mail address, alternative contact information, and standardized risk factor and medical history." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="13379" end="13383" sStart="null" offset="76" sid="r9.full.j.0900" wn="3" wnkey="full%5:00:00:complete:00" text="To be enrolled as a concordant sibling, the subject must have a full sibling enrolled as a proband in SWISS." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="14630" end="14634" sStart="null" offset="41" sid="r9.full.j.0276" wn="3" wnkey="full%5:00:00:complete:00" text="2) The subject has 2 or more full siblings who each have had an ischemic stroke and who are participating in the study." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="18238" end="18242" sStart="null" offset="348" sid="r9.full.j.0550" wn="2" wnkey="full%5:00:01:whole:00" text="The local coordinator completes the proband case report forms (CRFs), assigns a SWISS study number to the proband, forwards the proband CRFs to the Clinical Coordinating Center, and gives the proband (or surrogate) a set of study invitation letters to be sent to all of his or her living full siblings." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="30446" end="30452" sStart="null" offset="335" sid="r8.family.n.0997" wn="2" wnkey="family%1:14:00::" text="For more complex traits, the inheritance pattern does not fit a single-gene model, and methods that assume a genetic model may provide erroneous results [ 59 ] . Ischemic stroke clearly demonstrates familial aggregation, yet no single-gene model of transmission is consistent with the family data." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="567" end="573" sStart="null" offset="0" sid="r8.family.n.0753" wn="4" wnkey="family%1:14:01::" text="Family history and twins studies support the existence of genetic susceptibility to stroke [ 1 2 3 4 ] . Mendelian disorders known to be associated with an increased risk of stroke include hemoglobinopathies, dyslipoproteinemias, and cardioembolic disorders [ 5 ] . Most known Mendelian stroke disorders present in infancy, childhood, or young adulthood and collectively represent only a small proportion of all stroke cases." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="37785" end="37791" sStart="null" offset="163" sid="r8.family.n.0493" wn="2" wnkey="family%1:14:00::" text="This right cannot be waived by other members of the pedigree [ 72 ] . Therefore, probands or their noninvestigator surrogates invite other family members to participate." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="36613" end="36618" sStart="null" offset="0" sid="null" wn="1" wnkey="date%1:28:00::" text="For linking purposes, we use special study-specific codes, rather than medical record numbers, Social Security numbers, or an easily decoded combination of initials and birth &lt;b&gt;dates&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3951" end="3955" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To &lt;b&gt;date&lt;/b&gt;, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3951" end="3955" sStart="null" offset="0" sid="null" wn="5" wnkey="date%1:28:02::" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To &lt;b&gt;date&lt;/b&gt;, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3951" end="3955" sStart="null" offset="0" sid="null" wn="5" wnkey="date%1:28:02::" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To &lt;b&gt;date&lt;/b&gt;, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3951" end="3955" sStart="null" offset="0" sid="null" wn="5" wnkey="date%1:28:02::" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To &lt;b&gt;date&lt;/b&gt;, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3951" end="3955" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To &lt;b&gt;date&lt;/b&gt;, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="25385" end="25389" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:05::" text="The following information is collected on all living full siblings who return sibling response letters: name, &lt;b&gt;date&lt;/b&gt; of birth, gender, name of the proband they are related to, twin status, home address, home phone number, e-mail address, alternative contact information, and standardized risk factor and medical history." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="7496" end="7500" sStart="null" offset="0" sid="null" wn="4" wnkey="date%1:28:02::" text="The paucity of genome-wide scanning studies in the stroke literature to &lt;b&gt;date&lt;/b&gt; is mainly due to theoretical and logistical factors that make such studies difficult to design." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="25696" end="25700" sStart="null" offset="0" sid="null" wn="6" wnkey="date%1:28:05::" text="In addition, for each concordant sibling, we record &lt;b&gt;date&lt;/b&gt; of review of outside medical records, a stroke work-up checklist addressing medical reports reviewed by the physician member of the SVC who confirms stroke concordance, &lt;b&gt;date&lt;/b&gt; of onset of index stroke (and of first stroke, if sibling had more than one), TOAST subtype of index stroke, and responses to all items contained in the QVSFS." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="3421" end="3427" sStart="null" offset="497" sid="r10.common.j.0405" wn="4" wnkey="common%5:00:00:familiar:02" text="However, despite association of the factor V G1691A (factor V Leiden) and prothrombin (factor II) G20210A mutations with venous thromboembolism and myocardial infarction [ 10 11 ] , neither mutation is strongly associated with risk of stroke [ 12 13 14 15 16 17 18 ] . Although a study of British adults found elevated levels of serum homocysteine to be associated with an increased risk of stroke [ 19 ] , a case-control study of a common polymorphism (methylenetetrahydrofolate reductase [MTHFR] T677C) that results in increased serum homocysteine concentrations found no difference between patients with stroke and controls in either genotype or allele frequency [ 20 ] . Because antiplatelet agents with different mechanisms of action can bring about significant reductions in stroke risk, several platelet receptor genes have been tested as candidate stroke susceptibility genes [ 21 22 ] . To date, however, no compelling evidence for an association between any platelet receptor gene polymorphism and risk of stroke has been found." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="214" end="220" sStart="null" offset="29" sid="r10.common.j.0574" wn="2" wnkey="common%3:00:01::" text="In ischemic stroke, the most common type, a profound disturbance of focal cerebral blood flow leads to irreversible parenchymal injury." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="36579" end="36590" sStart="null" offset="165" sid="r11.combination.n.0104" wn="1" wnkey="combination%1:14:00::" text="For linking purposes, we use special study-specific codes, rather than medical record numbers, Social Security numbers, or an easily decoded combination of initials and birth dates." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="4" wnkey="chance%1:07:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="39710" end="39716" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="This method essentially searches for areas of the genome that are shared less often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="39710" end="39716" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="This method essentially searches for areas of the genome that are shared less often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="39710" end="39716" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="This method essentially searches for areas of the genome that are shared less often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2350-3-1.anc" start="38804" end="38810" sStart="null" offset="0" sid="null" wn="2" wnkey="chance%1:19:00::" text="The central approach this study takes is to identify areas of the genome that siblings affected by stroke share more often than one would expect by &lt;b&gt;chance&lt;/b&gt;." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="18293" end="18298" sStart="null" offset="40" sid="r8.ask.v.0397" wn="1" wnkey="ask%2:32:01::" text="In the letter, siblings are asked to indicate whether they are interested in participating in SWISS by completing the contact information section and sending it to the Clinical Coordinating Center." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="18293" end="18298" sStart="null" offset="40" sid="r8.ask.v.0397" wn="" wnkey="null" text="In the letter, siblings are asked to indicate whether they are interested in participating in SWISS by completing the contact information section and sending it to the Clinical Coordinating Center." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-3-1.anc" start="29924" end="29931" sStart="null" offset="277" sid="r11.absence.n.0421" wn="1" wnkey="absence%1:26:00::" text="The third (discordant) sibling is collected for purposes of determining potential nonpaternities in a sibship (more than 4 alleles) and for better estimating the proportion of alleles shared that are identical by state (in the absence of parents)." />
  </sentences>
</list>